432 related articles for article (PubMed ID: 16230210)
1. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
[TBL] [Abstract][Full Text] [Related]
2. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
[TBL] [Abstract][Full Text] [Related]
3. Catheter-related fungemia caused by Candida intermedia.
Ruan SY; Chien JY; Hou YC; Hsueh PR
Int J Infect Dis; 2010 Feb; 14(2):e147-9. PubMed ID: 19497773
[TBL] [Abstract][Full Text] [Related]
4. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
6. Azole resistance of Candida glabrata in a case of recurrent fungemia.
Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
[TBL] [Abstract][Full Text] [Related]
7. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
8. Candida glabrata fungemia: experience in a tertiary care center.
Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
[TBL] [Abstract][Full Text] [Related]
9. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
12. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
Wilson AG; Micek ST; Ritchie DJ
Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
[TBL] [Abstract][Full Text] [Related]
13. Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature.
Minces LR; Ho KS; Veldkamp PJ; Clancy CJ
Scand J Infect Dis; 2009; 41(11-12):892-7. PubMed ID: 19922077
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
[TBL] [Abstract][Full Text] [Related]
15. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
16. Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
Pasqualotto AC; Zimerman RA; Alves SH; Aquino VR; Branco D; Wiltgen D; do Amaral A; Cechinel R; Colares SM; da Rocha IG; Severo LC; Sukiennik TC
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):898-9. PubMed ID: 18785850
[No Abstract] [Full Text] [Related]
17. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
[TBL] [Abstract][Full Text] [Related]
18. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
[TBL] [Abstract][Full Text] [Related]
19. Massive septic thrombus formation on a superior vena cava indwelling catheter following Torulopsis (Candida) glabrata fungemia.
Gressianu MT; Dhruva VN; Arora RR; Patel S; Lopez S; Jihayel AK; Saric M
Intensive Care Med; 2002 Mar; 28(3):379-80. PubMed ID: 11904673
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia.
Tumbarello M; Posteraro B; Trecarichi EM; Sanguinetti M
Arch Intern Med; 2009 Aug; 169(15):1444-5; author reply 1445. PubMed ID: 19667313
[No Abstract] [Full Text] [Related]
[Next] [New Search]